CPHI (China Pharma Holdings) רווחיות מכירות לפי רווח גולמי

סמל תאגידי ולוגו של chinapharmaholdings.com (CPHI)

Geopolitical tensions between the US and China are limiting the global sales of China Pharma Holdings (CPHI), triggering a decline in profitability within the generics sector. The gross margin as a percentage of revenue on the GURU.Markets daily chart clearly confirms this trend, where the indicator reaches -57.00. Close cooperation with Chinese pharmacies and hospitals regarding the supply of affordable psychotropic drugs is stabilizing the situation.

CPHI - שולי רווח גולמי China Pharma Holdings, Inc. בטווח 04.07.2022 - 20.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת China Pharma Holdings, Inc. (CPHI)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
הערכת שווי פונדמנטלית:China Pharma Holdings (CPHI)
מוצרים מיוצרים של chinapharmaholdings.com

The fundamental stability of China Pharma Holdings (CPHI) depends on management's ability to optimize direct production costs. The implementation of ESG standards and the greening of raw material supply chains directly impact the cost of goods sold, which is reflected in profit dynamics. By analyzing the estimated gross margin, an investor can see the portion of revenue remaining after deducting material costs, thereby assessing the efficiency of resource control and the risk of overpaying for the asset.